Specify a stock or a cryptocurrency in the search bar to get a summary
Anteris Technologies Ltd
AVRAnteris Technologies Ltd, a structural heart company, engages in the designing, developing, and commercializing medical devices. The company's lead product candidate is DurAVR, a transcatheter heart valve (THV) for the treatment of aortic stenosis. It also offers ComASUR, a delivery system that provides controlled deployment and placement of the DurAVR THV with balloon-expandable delivery, which allow precise alignment of the heart's native commissures to achieve ideal valve positioning; and ADAPT, a patented anti-calcification tissue technology. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Address: Toowong Tower, Toowong, QLD, Australia, 4066
Analytics
WallStreet Target Price
40.31 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures AVR
Dividend Analytics AVR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AVR
Stock Valuation AVR
Financials AVR
Results | 2019 | Dynamics |